Trade Summary

5 days ago, Francis Knuettel II, serving as CFO, Treas & Secty at Pelthos Therapeutics Inc. (PTHS), sold 1,500 shares at $26.84 per share, for a total transaction value of $40,264.95. Following this transaction, Francis Knuettel II now holds 11,316 shares of PTHS.

This sale represents a 11.70% decrease in Francis Knuettel II's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 7:17 PM ET, 4 days after the trade was made.

Pelthos Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.